Nanoemulsion Vaccine
Nanoemulsion Vaccine - Related Videos
01:50
Preparation of a Nanoemulsion Adjuvant Vaccine
0 Views •
2025
This video demonstrates the production of nanoemulsion tumor vaccines. The stable oil reservoir depots carrying synthetic peptides and adjuvants are produced by low-energy nanoemulsion, offering significant promise for tumor immunotherapy.
08:15
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
0 Views •
Cited by 2 •
2022
The protocol presents detailed methods for evaluating whether the nanoemulsion ophiopogonin D adjuvant promotes effective cellular immune responses.
01:51
Vaccinations
0 Views •
2019
Overview Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
07:33
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
0 Views •
Cited by 1 •
2022
Here, we present detailed methods for the preparation and evaluation of the nasal self-assembled nanoemulsion tumor vaccine in vitro and in vivo.
06:17
Expression and Purification of Virus-like Particles for Vaccination
0 Views •
Cited by 27 •
2016
Here, we present a protocol for synthesizing virus-like particles using either baculovirus or mammalian expression systems, and ultracentrifugation purification. This highly customizable approach is used to identify viral antigens as vaccine targets in a safe and flexible manner.
FAQs
The nanoscale oil-and-water droplets can protect or carry antigen and promote its uptake by antigen-presenting cells. Once these cells encounter the formulation, activation of innate immune signaling can help organize downstream adaptive responses. This mechanism is important because efficient antigen handling and innate stimulation may support stronger B-cell and T-cell responses than antigen delivery alone.
Innate immune signaling provides early cues that shape the later adaptive response. In this formulation, the droplets can stimulate those signals while delivering antigen, helping support the development of protective B- and T-cell activity. Understanding this interaction allows immunology researchers to examine how the formulation contributes to response strength rather than treating antigen exposure as the only determining factor.
Nanoemulsion composition is tunable, so researchers can investigate how formulation characteristics influence antigen delivery and immune stimulation. Physical stability also matters because a stable preparation may preserve the intended delivery system during vaccine evaluation. These properties are studied alongside immune responses to determine whether a formulation can provide consistent antigen handling and support durable, targeted immunity.
The formulation’s tunable composition and physical stability may support more than one vaccination route, including needle-based and mucosal administration. Route selection is relevant because researchers can compare how the same delivery concept performs in different exposure settings. Studies then examine safety, biodistribution, and immune response to determine whether the approach is suitable for a particular infectious-disease prevention strategy.
Evaluation begins with examining the formulation’s antigen delivery properties and its interaction with antigen-presenting cells. Researchers then assess safety, biodistribution, and the resulting immune response. These measurements connect the physical delivery system with biological outcomes, helping determine whether the candidate supports protective immunity and whether its behavior is appropriate for further infectious-disease investigation.
Researchers may investigate this approach when an infectious disease requires durable or targeted immunity and antigen delivery alone may not provide sufficient immune stimulation. The nanoemulsion can combine antigen carriage with innate signaling, while studies assess B- and T-cell responses, safety, and biodistribution. This makes the platform relevant for exploring vaccine strategies against pathogens with demanding immune-protection requirements.